Form D · Biotechnology
Novum Medical, Inc.
Woburn, MA · CIK 0001492254
Offering snapshot reported Dec 13, 2021 · SEC filing
- Reported sold
- $900K Offering amount: $1.8M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Nov 30, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2021 | Initial | $900,000 | No comparison | 2 | SEC filing |
| Dec 17, 2020 | Initial | $3,194,000 | No comparison | 24 | SEC filing |
| Sep 9, 2019 | Amendment | $4,308,791 | $0vs Sep 6, 2019 | 27 | SEC filing |
| Sep 6, 2019 | Initial | $4,308,791 | No comparison | 27 | SEC filing |
| Sep 11, 2018 | Initial | $4,499,744 | No comparison | 26 | SEC filing |
| Sep 1, 2016 | Initial | $356,249 | No comparison | 8 | SEC filing |
| Jul 2, 2010 | Initial | $1,100,064 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-424756
Source: Form D, filed Dec 13, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas A. Afzal | Director, Executive |
| Ted Bird | Director |
| Cheryl Blanchard | Director |
| David Gill | Director |
| Donald Grimm | Director |
| Huntbrew Partnership Huntbrew Partnership | Promoter |
| Richard Intrater | Director |
| Gary Jacobs | Director |
| Douglas Kohrs | Director |
| Debora La Budde | Director |
| Robert Lachenauer | Director, Executive |
| Arpesh Mehta | Director |
| Paul Nichols | Director |
| Paul K. Nichols, Jr. | Director, Executive |
| Arthur O'dea | Executive |
| Art O/Dea | Executive |
| Adam Wallen | Director, Executive |
| Pieter Wolters | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12 R Cabot Road
Woburn, MA, 01801
Woburn, MA, 01801